MDxHealth S.A.
MDXH
Rangering i aksjer
#21739
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Aksjekurs
$3.39
Sist synkronisert: 2023-12-15
Markedsverdi
$96.16M
Endring (1 dag)
-1.73%
Endring (1 år)
0.01%
Land
BE
Handel MDxHealth S.A. (MDXH)
Kategori
Healthcare
Historikk for aksjesplitt for MDxHealth S.A. (MDXH)
Aksjen MDxHealth S.A. (symbol: MDXH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MDXH-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MDXH-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én MDXH-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 MDXH-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
